FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagehl7.fhir.uv.ebm
Resource TypeGroup
IdGroup-236532.json
FHIR VersionR6

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: Group 236532

version: 70; Last updated: 2026-01-29 20:43:03+0000; Language: en

Profile: ConceptualExposureDefinition

Artifact Author: Computable Publishing®: MAGIC-to-FEvIR Converter:

Artifact related artifact: No display for RelatedArtifact (type: part-of; resourceReference: ->display: string (PrimitiveType/Group.extension[1].value[x].resourceReference.display): element = string -> display=string[MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes])

CiteAs:

InterventionDefinition: Glucagon-Like Peptide-1 (GLP-1) receptor agonists [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236532. Revised 2026-01-29. Available at: https://fevir.net/resources/Group/236532. Computable resource at: https://fevir.net/resources/Group/236532#json.

url: https://fevir.net/resources/Group/236532

identifier: FEvIR Object Identifier/236532, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-intervention-85390-I-85789

name: Glucagon_Like_Peptide_1_GLP_1_receptor_agonists85390_I_85789

title: InterventionDefinition: Glucagon-Like Peptide-1 (GLP-1) receptor agonists

status: Active

publisher: Computable Publishing LLC

contact: support@computablepublishing.com

description:

This Group Resource is referenced in an example for the EBMonFHIR Implementation Guide.

UseContexts

-CodeValue[x]
*Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication (Evidence Communication)ConceptualExposureDefinition

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

membership: Conceptual


Source1

{
  "resourceType": "Group",
  "id": "236532",
  "meta": {
    "versionId": "70",
    "lastUpdated": "2026-01-29T20:43:03.385Z",
    "profile": [
      "http://hl7.org/fhir/uv/ebm/StructureDefinition/conceptual-exposure-definition"
    ]
  },
  "language": "en",
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/artifact-author",
      "valueContactDetail": {
        "name": "Computable Publishing®: MAGIC-to-FEvIR Converter"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact",
      "valueRelatedArtifact": {
        "type": "part-of",
        "resourceReference": {
          "type": "Composition",
          "identifier": {
            "type": {
              "text": "FEvIR Linking Identifier"
            },
            "system": "https://fevir.net/FLI",
            "value": "MAGIC-5288-j1Wqrn-conversion-report",
            "assigner": {
              "display": "Computable Publishing LLC"
            }
          },
          "display": "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes"
        }
      }
    },
    {
      "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as",
      "valueMarkdown": "InterventionDefinition: Glucagon-Like Peptide-1 (GLP-1) receptor agonists [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236532. Revised 2026-01-29. Available at: https://fevir.net/resources/Group/236532. Computable resource at: https://fevir.net/resources/Group/236532#json."
    }
  ],
  "url": "https://fevir.net/resources/Group/236532",
  "identifier": [
    {
      "type": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code": "ACSN",
            "display": "Accession ID"
          }
        ],
        "text": "FEvIR Object Identifier"
      },
      "system": "https://fevir.net/FOI",
      "value": "236532",
      "assigner": {
        "display": "Computable Publishing LLC"
      }
    },
    {
      "type": {
        "text": "FEvIR Linking Identifier"
      },
      "system": "https://fevir.net/FLI",
      "value": "MAGIC-5288-j1Wqrn-intervention-85390-I-85789",
      "assigner": {
        "display": "Computable Publishing LLC"
      }
    }
  ],
  "name": "Glucagon_Like_Peptide_1_GLP_1_receptor_agonists85390_I_85789",
  "title": "InterventionDefinition: Glucagon-Like Peptide-1 (GLP-1) receptor agonists",
  "status": "active",
  "publisher": "Computable Publishing LLC",
  "contact": [
    {
      "telecom": [
        {
          "system": "email",
          "value": "support@computablepublishing.com"
        }
      ]
    }
  ],
  "description": "This Group Resource is referenced in an example for the EBMonFHIR Implementation Guide.",
  "useContext": [
    {
      "code": {
        "system": "https://fevir.net/resources/CodeSystem/179423",
        "code": "evidence-communication",
        "display": "Evidence Communication"
      },
      "valueCodeableConcept": {
        "coding": [
          {
            "system": "https://fevir.net/resources/CodeSystem/179423",
            "code": "ConceptualExposureDefinition",
            "display": "ConceptualExposureDefinition"
          }
        ]
      }
    }
  ],
  "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/",
  "membership": "conceptual"
}